Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.490
-0.070 (-4.49%)
At close: Oct 7, 2025, 4:00 PM EDT
1.540
+0.050 (3.36%)
After-hours: Oct 7, 2025, 6:52 PM EDT
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of $396.55 million as of October 7, 2025. Its market cap has decreased by -61.29% in one year.
Market Cap
396.55M
Enterprise Value
255.43M
1-Year Change
-61.29%
Ranking
Category
Stock Price
$1.49
Market Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from $969.66M to $396.55M, a decrease of -59.10%. That is a compound annual growth rate of -11.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 415.18M | -33.61% |
| Dec 31, 2024 | 625.39M | -44.17% |
| Dec 29, 2023 | 1.12B | 240.67% |
| Dec 30, 2022 | 328.81M | -13.12% |
| Dec 31, 2021 | 378.45M | -19.06% |
| Dec 31, 2020 | 467.55M | -21.26% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |